# Exploring Zanidatamab’s efficacy across HER2-positive Malignancies: a narrative review

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/exploring-zanidatamab-s-efficacy-across-her2-positive-malignancies-a-narrative/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Warisha Kanwal,Kaneez Narjis,Sarah Musani,Fnu Nancy,Laiba Qureshi,Muhammad Mudasir,R. Naseem,Fnu Tooba,Juvairia Yousuf,Kanza Farhan,Hadiya Javed,Mohammed Mahmmoud Fadelallah Eljack |
| Citations | 7 |
| DOI | 10.1186/s12885-025-13749-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-025-13749-1 |
| OpenAlex ID | https://openalex.org/W4408079443 |
| PMID | 40025472 |
| Type | review |
| Year | 2025 |

## Paper authors

- [Kanza Farhan](https://scholariq.org/researchers/kanza-farhan/)

## Paper journal

- [BMC Cancer](https://scholariq.org/journals/bmc-cancer/)

## Paper primary topic

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Paper topics

- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.